RingConn, one of the leading manufacturers of smart rings, is causing a stir at this year’s IFA in Berlin. From September 5 to 9, the company will be presenting a blood pressure feature for the first time in Hall 15, Stand 105, which is set to become part of the RingConn product family in the future. Visitors will be able to try out the technology in a demo before it is officially integrated into the devices next year. RingConn is thus taking an important step towards preventive health monitoring in everyday life.
- New blood pressure feature presented for the first time as a demo at IFA 2025
- One-off calibration with cuff device, then continuous measurements via the app
- Early detection of hypertension patterns through regular monitoring
- Already over 250,000 RingConn users worldwide with Gen 2 and Gen 2 Air
Progress on one of the biggest challenges in the wearable industry
Continuous blood pressure monitoring is still considered one of the most difficult issues in the wearable sector. While pulse, sleep and oxygen saturation have long been reliably measured, the precise recording of blood pressure has so far required complex devices with cuffs. RingConn has been working on breaking through this barrier since its foundation.
At IFA 2025, the company is now showcasing a decisive step forward: the feature presented is intended to enable users to measure their blood pressure regularly and directly on their finger without additional devices. An important aspect is the one-off calibration with a conventional measuring device every 28 days. The ring then delivers daily values to the associated app. This data helps to identify trends in blood pressure that often remain hidden with sporadic measurements.
The approach is particularly relevant in view of the global dimension of the problem: According to the WHO, more than 1.1 billion people worldwide suffer from high blood pressure, but less than a fifth have the disease under control. Early and regular monitoring can help to identify risks such as heart attacks, strokes or organ damage in good time and take countermeasures.
Potential for health management in everyday life
RingConn emphasizes that the new feature goes far beyond a pure measurement function. Continuous monitoring can also detect hidden patterns – such as nocturnal hypertension, white coat effects or slow changes over longer periods of time. These factors often go undetected with occasional measurements, but are crucial for correct diagnosis and treatment.
For users, this means that health information can be seamlessly integrated into everyday life. The smart ring is inconspicuous, can be worn around the clock and, unlike blood pressure cuffs, offers convenient use without a great deal of effort. At the same time, RingConn is announcing a voluntary test phase in which interested users can test the function at an early stage and provide feedback. This should help to further optimize the accuracy and reliability of the feature before it is launched on the market.
Growing presence on the wearable market
With the existing RingConn Gen 2 and Gen 2 Air models, the company has already created a solid foundation. Over 250,000 users worldwide are now using the smart rings – a clear indication of the growing demand for wearable health solutions. The new blood pressure feature could further strengthen this trend and further consolidate RingConn’s position in global competition with other wearable manufacturers.
RingConn Gen 2 & Gen 2 Air: Smarte Ringe starkem Gesundheits-Tracking und KI-Features
Conclusion
With the presentation of the blood pressure feature at IFA 2025, RingConn marks an important milestone in the further development of smart health devices. The ability to measure blood pressure values regularly and easily on the finger could have a lasting impact on personal health management. The function is still in the test phase, with the official market launch expected in 2026. Interested parties can already get an idea of how wearable technologies will support the prevention and early detection of diseases in the future at IFA.
